Akoya Biosciences Inc (AKYA)
3.80
-0.02
(-0.52%)
USD |
NASDAQ |
Apr 26, 16:00
3.81
+0.01
(+0.26%)
After-Hours: 20:00
Akoya Biosciences Enterprise Value: 179.85M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 179.85M |
April 24, 2024 | 179.36M |
April 23, 2024 | 179.36M |
April 22, 2024 | 183.78M |
April 19, 2024 | 178.86M |
April 18, 2024 | 181.32M |
April 17, 2024 | 184.27M |
April 16, 2024 | 187.71M |
April 15, 2024 | 189.18M |
April 12, 2024 | 195.08M |
April 11, 2024 | 203.43M |
April 10, 2024 | 203.43M |
April 09, 2024 | 206.87M |
April 08, 2024 | 199.50M |
April 05, 2024 | 206.38M |
April 04, 2024 | 199.50M |
April 03, 2024 | 204.91M |
April 02, 2024 | 208.84M |
April 01, 2024 | 216.21M |
March 28, 2024 | 222.60M |
March 27, 2024 | 224.56M |
March 26, 2024 | 219.65M |
March 25, 2024 | 233.90M |
March 22, 2024 | 227.51M |
March 21, 2024 | 237.34M |
Date | Value |
---|---|
March 20, 2024 | 239.80M |
March 19, 2024 | 239.31M |
March 18, 2024 | 234.88M |
March 15, 2024 | 233.41M |
March 14, 2024 | 230.95M |
March 13, 2024 | 232.92M |
March 12, 2024 | 230.95M |
March 11, 2024 | 230.46M |
March 08, 2024 | 237.83M |
March 07, 2024 | 226.04M |
March 06, 2024 | 235.87M |
March 05, 2024 | 242.75M |
March 04, 2024 | 285.99M |
March 01, 2024 | 288.45M |
February 29, 2024 | 274.20M |
February 28, 2024 | 270.27M |
February 27, 2024 | 279.11M |
February 26, 2024 | 258.35M |
February 23, 2024 | 261.79M |
February 22, 2024 | 254.91M |
February 21, 2024 | 250.98M |
February 20, 2024 | 268.66M |
February 16, 2024 | 284.87M |
February 15, 2024 | 277.99M |
February 14, 2024 | 262.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
138.79M
Minimum
Oct 27 2023
953.89M
Maximum
Apr 16 2021
375.62M
Average
360.27M
Median
Jun 20 2023
Enterprise Value Benchmarks
Bruker Corp | 11.92B |
Azenta Inc | 1.888B |
Harvard Bioscience Inc | 186.78M |
Bionano Genomics Inc | 14.39M |
Singular Genomics Systems Inc | -135.42M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -10.80M |
Revenue (Quarterly) | 26.49M |
Total Expenses (Quarterly) | 35.31M |
EPS Diluted (Quarterly) | -0.20 |
Gross Profit Margin (Quarterly) | 62.75% |
Profit Margin (Quarterly) | -40.78% |
Earnings Yield | -38.32% |
Normalized Earnings Yield | -37.49 |